Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Aravind Ravi Kumar"'
Autor:
Louise Kathleen Kostos, William Yu Ching Lai, Peter Lambroglou, Elizabeth Medhurst, James Patrick Buteau, Shahneen Sandhu, Ben Tran, Lavinia Anne Spain, Ciara Conduit, Roslyn Wallace, Ramin Alipour, Timothy J. Akhurst, Grace Kong, Anthony Cardin, Javad Saghebi, Aravind Ravi Kumar, Michael S Hofman, Arun Azad
Publikováno v:
Journal of Clinical Oncology. 41:77-77
77 Background: [177Lu]Lu-PSMA (LuPSMA) is currently FDA-approved for use in the post-taxane, post-antiandrogen setting in pts with mCRPC. Little is known about the efficacy of treatment in pts with subsequent progression after LuPSMA. In this single-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c857bd4c6a9a327b50ded5ac6f25112e
https://doi.org/10.1200/jco.2023.41.6_suppl.77
https://doi.org/10.1200/jco.2023.41.6_suppl.77
Autor:
Price, Jackson, Michael, Hofman, Lachlan, McIntosh, James Patrick, Buteau, Aravind, Ravi Kumar
Publikováno v:
Seminars in nuclear medicine. 52(2)
Radionuclide therapy using the small molecule PSMA bound to the beta-emitting radionuclide, Lutetium-177 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82a17c3966a1f2d341378b0fa3a38602
https://pubmed.ncbi.nlm.nih.gov/34893320
https://pubmed.ncbi.nlm.nih.gov/34893320
Autor:
Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Lavinia Anne Spain, Lisa Horvath, Megan Crumbaker, Angelyn Anton, Roslyn Wallace, Anupama Pasam, Mathias Bressel, Erin Cassidy, Patricia Banks, Nattakorn Dhiantravan, Timothy J. Akhurst, Aravind Ravi Kumar, Ramin Alipour, Mark Scalzo, Scott Williams, Rodney Hicks, Michael S Hofman
Publikováno v:
Journal of Clinical Oncology. 40:5017-5017
5017 Background: The VISION and TheraP trials have established the safety and efficacy of 177Lu-PSMA-617 in mCRPC with a 50% PSA response rate (PSA50-RR) of 46% and 66% and median progression free survival (PFS) of 8.7 and 5.1 months, respectively. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::162c9bea57caad54dd2b4c22946d68ea
https://doi.org/10.1200/jco.2022.40.16_suppl.5017
https://doi.org/10.1200/jco.2022.40.16_suppl.5017
Autor:
John, Violet, Shahneen, Sandhu, Amir, Iravani, Justin, Ferdinandus, Sue-Ping, Thang, Grace, Kong, Aravind Ravi, Kumar, Tim, Akhurst, David A, Pattison, Alexis, Beaulieu, Jennifer, Mooi, Ben, Tran, Christina, Guo, Victor, Kalff, Declan G, Murphy, Price, Jackson, Peter, Eu, Mark, Scalzo, Scott, Williams, Rodney J, Hicks, Michael S, Hofman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 61(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::befb53f19701961af0f77cbe3d8b9b06
https://pubmed.ncbi.nlm.nih.gov/32073970
https://pubmed.ncbi.nlm.nih.gov/32073970
Autor:
Sue Ping, Thang, John, Violet, Shahneen, Sandhu, Amir, Iravani, Tim, Akhurst, Grace, Kong, Aravind, Ravi Kumar, Declan G, Murphy, Scott G, Williams, Rodney J, Hicks, Michael S, Hofman
Publikováno v:
European urology oncology. 2(6)
Prostate-specific membrane antigen (PSMA) is overexpressed in metastatic castration-resistant prostate cancer (mCRPC) and represents a target for imaging and therapy. We undertook a prospective trial ofTo determine outcomes for men screened for the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::832be8b6462ff64d57d051e806453398
https://pubmed.ncbi.nlm.nih.gov/31412006
https://pubmed.ncbi.nlm.nih.gov/31412006
Autor:
John, Violet, Price, Jackson, Justin, Ferdinandus, Shahneen, Sandhu, Tim, Akhurst, Amir, Iravani, Grace, Kong, Aravind Ravi, Kumar, Sue Ping, Thang, Peter, Eu, Mark, Scalzo, Declan, Murphy, Scott, Williams, Rodney J, Hicks, Michael S, Hofman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 60(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5cb8a6407a234962e9d18f5ae987f6ed
https://pubmed.ncbi.nlm.nih.gov/30291192
https://pubmed.ncbi.nlm.nih.gov/30291192
Autor:
Glenna, Gibson, Aravind Ravi, Kumar, Karin, Steinke, Farzad, Bashirzadeh, Rebecca, Roach, Morgan, Windsor, Robert, Ware, David, Fielding
Publikováno v:
Internal medicine journal. 47(12)
Clinical prediction models and 18-fluorine-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) are used for the assessment of solitary pulmonary nodules (SPN); however, a biopsy is still required before treatment, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b58bfa42c1a7949782d9507b739289f9
https://pubmed.ncbi.nlm.nih.gov/28782248
https://pubmed.ncbi.nlm.nih.gov/28782248
Autor:
Aravind Ravi Kumar
Publikováno v:
Australian Prescriber. 31:123-128
Positron emission tomography (PET) allows diagnostic imaging of metabolic function using radioisotopes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1ee6cc2247adf4fc8967e798794ab1a
https://doi.org/10.18773/austprescr.2008.071
https://doi.org/10.18773/austprescr.2008.071
Autor:
Phan, Nguyen, Farzad, Bashirzadeh, Justin, Hundloe, Olivier, Salvado, Nicholas, Dowson, Robert, Ware, Ian Brent, Masters, Aravind, Ravi Kumar, David, Fielding
Publikováno v:
Respirology (Carlton, Vic.). 20(6)
Expert analysis of endobronchial ultrasound mini probe (EBUS-MP) images has established subjective criteria for discriminating benign and malignant disease. Minimal data are available for objective analysis of these images. The aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8771d8cd3e9274138099bfd8c3bf1bb8
https://pubmed.ncbi.nlm.nih.gov/26113224
https://pubmed.ncbi.nlm.nih.gov/26113224